| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7fd38ff393036b78f4fa402ddeeae2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f84747e8d08b1023763356d0e7d1db68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ab2d714181eae13dd7cdead6e6fdaf3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70503
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2010-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7d1a8f5616a9da52355e9a52f3ac13d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef2f532ff70699d3f94bec20793a00ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c93f37361196d1e3ffc8bb8ff7ddd3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2dcabb737454eaf03d8a33888f82e2a |
| publicationDate |
2014-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2486673-T3 |
| titleOfInvention |
Use of NKp46 to prevent type I diabetes |
| abstract |
A composition comprising at least one protein and a pharmaceutically acceptable carrier, wherein the protein is selected from the group consisting of: a protein comprising a fragment isolated from the extracellular region of NKp46; an antibody specific for the extracellular region of NKp46, and a combination thereof, for use in the prevention or treatment of type 1 diabetes. |
| priorityDate |
2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |